NORTH CHICAGO, Ill. and SOUTH SAN FRANCISCO, Calif., June 26, 2018 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, and Calico, a company focused on aging research and therapeutics, today announced an extension of their collaboration to discover, develop and bring to market new therapies for patients with age-related diseases, including neurodegeneration and cancer. Calico is the Alphabet-backed …